Colin Goding lab

Our interests lie in understanding how phenotypic heterogeneity is generated within cancer, and what are the molecular mechanisms that drive three major barriers to effective therapy: microenvironment-driven metastatic spread, dormancy, and phenotypic drug-resistance. Our long-term aim is to develop effective therapies for cancer that take phenotypic heterogeneity into account.